Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

3rd International Definiens Symposium to be Held in Munich from June 14-16, 2012

Published: Monday, April 23, 2012
Last Updated: Monday, April 23, 2012
Bookmark and Share
Program features latest trends in quantitative digital pathology and tissue-based biomarker development with leading experts from Roche, AstraZeneca, Novartis and cutting-edge biomedical image and data analysis during hands-on workshops.

Definiens® invites professionals interested in pathology and biomarker development to the 3rd International Definiens Symposium. The symposium will be held at the Definiens headquarters in Munich from June 14-16, 2012.

The annual event is the premier forum for the latest trends in quantitative research in histology, tissue-based biomarker development and cutting-edge biomedical image and data analysis. It brings together experts from around the world to share best practices and experiences. This year’s keynote lecture will be delivered by Dr. Frauke Bentzien from Exelixis, one of the pioneers in quantitative digital pathology who has been successfully applying this new paradigm in preclinical safety studies and clinical trials for many years.

The Definiens Symposium offers attendees the opportunity to network with peers and renowned experts and learn from their approaches and experiences. A one-day pre-conference workshop will provide hands-on experiences and training on the latest Definiens solutions for image analysis and data mining.

Nobel Laureate Prof. Gerd Binnig, Founder and CTO Definiens, will share his vision for the next generation of pathology tools, while leading experts from Roche, AstraZeneca, Novartis, GlaxoSmithKline and Johnson & Johnson, as well as practitioners from other renowned institutions, will contribute insights from their work. To find the full speaker panel and the workshop program, visit http://www.definiens.com/community/symposium.html.

“We are delighted to have such a distinguished group of speakers,” stated Thomas Heydler, CEO of Definiens. “The digital pathology market is quickly transitioning into a second phase of adoption where quantitative approaches allow us to unveil the real value of digital slides and are currently transforming pathology into a quantitative discipline. By bringing together thought leaders, experts and users, the International Definiens Symposium provides a very stimulating forum for learning about the future of this exciting field.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
New Cancer Drug Target Found in Dual-Function Protein
Findings from a study from TSRI have shown that targeting a protein called GlyRS might help to halt cancer growth.
HIV Structure Stabilized
Findings represent ‘big accomplishment’ in biomedical engineering and design.
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
“Amazing Protein Diversity” Discovered in Maize
The genome of the corn plant – or maize, as it’s called almost everywhere except the US – “is a lot more exciting” than scientists have previously believed. So says the lead scientist in a new effort to analyze and annotate the depth of the plant’s genetic resources.
Proteins in Blood of Heart Disease Patients May Predict Adverse Events
Nine-protein test shown superior to conventional assessments of risk.
Self-Assembling Protein Shell for Drug Delivery
Made-to-order nano-cages open possibilities of shipping cargo into living cells or fashioning small chemical reactors.
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Nanoprobe Enables Measurement of Protein Dynamics in Living Cells
Mass. General and Harvard researchers use device to measure how anesthetic affects levels of Alzheimer's-associated proteins.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!